EXAM 2 - Drugs Flashcards
PD-L1 Inhibitors (lung cancer)
immune checkpoint inhibitors
Pembrolizumab
Atezolizumab
Cemiplimab
Nivolumab + ipilimumab
EGFR exon 19 deletion or 1858R mutation (lung cancer)
Osimertinib
Erlotinib
Afatinib
ALK rearrangements (lung cancer)
Alectinib
Brigatinib
Loraltinib
ROS1 rearrangements (lung cancer)
Crizotinib
Enterctinib
BRAF V600E mutation (lung cancer)
Trametinib
Dabrafenib
Capmatinib
Tepotinib
RET rearrangement (lung cancer)
Selpercatinib
Pralsetinib
NTKR gene fusion positive
Larotrectinib
KRAS G12C mutation
Sotorasib
VEGF inhibitor
Bevacizumab
Antimicrotubule inhibitor
Cabazitaxel
Docetaxel
PARP inhibitor
Olaparib
Rucaparib
androgen synthesis inhibitors
abiraterone acetate
ketoconazole
LHRH agonists
Goserelin
Leuprolide
Triptorelin
LHRH/GnRH antagonists
Degarelix
Relugolix
1st generation antiandrogens
Bicalutamide
Flutamide
Nilutamide